Old Web
English
Sign In
Acemap
>
authorDetail
>
Hidetomo Matsumoto
Hidetomo Matsumoto
Bevacizumab
KRAS
Phases of clinical research
Colorectal cancer
Internal medicine
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
2016
Oncology
Motoki Yoshida
Akinori Takagane
Yasuhiro Miyake
Ken Shimada
Naoki Nagata
Atsushi Sato
Yutaka Ogata
Mutsumi Fukunaga
Koki Otsuka
Takao Takahashi
Hidetomo Matsumoto
Tatsuo Kagimura
Akihito Tsuji
Show All
Source
Cite
Save
Citations (9)
A phase II study on third-line chemotherapy combined bevacizumab with S-1 for metastatic colorectal cancer with mutated KRAS: SAVIOR study.
2013
Journal of Clinical Oncology
Akinori Takagane
Yasuhiro Miyake
Kouji Kobayashi
Naoki Nagata
Atsushi Sato
Yutaka Ogata
Mutsumi Fukunaga
Koki Otsuka
Takao Takahashi
Hidetomo Matsumoto
Yuji Negoro
Yoshihiro Matsubara
Motoki Yoshida
Show All
Source
Cite
Save
Citations (1)
1